Table
1: Descriptive
characteristics of women ages 14-26 years who received human papillomavirus
vaccine from 2010-2012 (n = 201).
Variable |
n |
% |
Demographic |
|
|
Race/Ethnicity |
||
Non-Hispanic Black |
138 |
68.6 |
Non-Hispanic White |
17 |
8.4 |
Hispanic |
35 |
17.4 |
Others |
11 |
5.4 |
Age (in years) |
||
14-19 |
46 |
22.9 |
20-22 |
76 |
37.8 |
23-24 |
43 |
21.4 |
25-26 |
36 |
17.9 |
Insurance Statusa |
||
Self-Pay |
117 |
63.6 |
Private |
6 |
3.3 |
Public |
61 |
33.2 |
Medical/Obstetric history |
||
Contraceptive Usea |
||
Tier 1 |
20 |
15 |
Tier 2 |
81 |
60.9 |
Tier 3 |
32 |
24.1 |
Recent STIa |
||
No |
160 |
84.2 |
Yes |
30 |
15.8 |
Paritya |
||
0 |
135 |
69.6 |
1 |
41 |
21.1 |
≥ 2 |
18 |
9.3 |
Visit type at the
first dosea |
||
Condition-Oriented |
55 |
28.2 |
Contraceptive Management |
80 |
41 |
Immunization |
24 |
12.3 |
Preventive |
36 |
18.5 |
aMissing values-17 for insurance
status, 68 for contraceptive use, 11 for recent STI, 7 for parity, 6 for visit
type at first dose.